Lankacidin C
Product Specifications
UNSPSC Description
Lankacidin C is an inhibitor of protein synthesis in vitro. Lankacidin C inhibits the activity of L1210 leukemia, B16 melanoma and 6C3 HED/OG lymphosarcoma cell lines. Lankacidin C has antibacterial activity and antitumor activity[1][2].
Target Antigen
Antibiotic; Bacterial
Type
Natural Products
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Infection
Assay Protocol
https://www.medchemexpress.com/lankacidin-c.html
Solubility
10 mM in DMSO
Smiles
C[C@@H]1[C@H]2C[C@H](O)/C=C/C(C)=C/C[C@H](O)/C=C/C(C)=C/[C@@H](NC(C(C)=O)=O)[C@@](C(O2)=O)(C)C1=O
Molecular Weight
459.53
References & Citations
[1]Cai L, et al. Modular Approaches to Lankacidin Antibiotics. J Am Chem Soc. 2020 Sep 2;142(35):15116-15126.|[2]Ootsu K, et al. Effects of Lankacidin group (T2636) antibiotics on the tumor growth and immune response against sheep erythrocytes in mice. Gan. 1973 Oct;64(5):481-92.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-121412/Lankacidin-C-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-121412/
Clinical Information
No Development Reported
CAS Number
23623-31-6
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
